Calysta

Calysta, Inc. is a biotechnology company that focuses on developing and manufacturing protein ingredients from innovative sources. Based in Menlo Park, California, with additional locations in Houston, London, Stavanger, and Singapore, the company provides nutritional feeds and health products for fish and livestock. Calysta also produces chemicals utilized in various end products, including fibers, plastics, and building materials, as well as biofuels derived from methane. With a commitment to sustainability, Calysta aims to address the increasing global demand for protein and ensure food security worldwide. The company has formed a strategic partnership with Bluestar Adisseo Company and was originally established in 2011 as a spinout of DNA2.0, a leading provider of synthetic genes.

Keysha Bailey

CFO

Thomas JG Huot

COO

1 past transactions

BioProtein

Acquisition in 2014
BioProtein AS and Bioprotein International AS are companies involved in research, development and commersialization of gas based fermentations, and BioProtein technology. BioProtein AS is owned by the Norwegian University of Life Sciences (UMB), International Research Institute of Stavanger (IRIS) and UNIFOB The Foundation of University Research Bergen. BioProtein AS is responsible for research and development while BioProtein International AS commercialises gas based fermentation and BioProtein Technology. BioProtein is produced using natural gas as its sole carbon and energy source, and can be used as a high quality nutritional protein in feed for several animal species. BioProtein has documented functional properties. The company's research and development is based on the owners' expertise which covers the entire value chain, from functional genomics to process technology to nutrition metabolism and animal health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.